On August 29, 2025, Ironwood Pharmaceuticals, Inc. confirmed that it has regained compliance with Nasdaq's minimum bid price requirement after its stock price exceeded $1.00 for 10 consecutive business days, following a previous non-compliance notice received on May 28, 2025. This event is significant for the company as it maintains its listing on the Nasdaq Global Select Market.